The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 13, 2022
Filed:
Oct. 02, 2020
Applicant:
University of Georgia Research Foundation, Inc., Athens, GA (US);
Inventors:
Donald A. Harn, Athens, GA (US);
Rafaella Queiroz, Minas Gerais, BR;
Lisa Shollenberger, Norfolk, VA (US);
Emily-Joy Farah Samli, Athens, GA (US);
Assignee:
University of Georgia Research Foundation, Inc., Athens, GA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/39 (2006.01); A61K 39/00 (2006.01); A61K 39/104 (2006.01); A61K 39/12 (2006.01); A61K 9/00 (2006.01); A61K 9/06 (2006.01); A61K 39/02 (2006.01); A61K 39/145 (2006.01); A61K 39/29 (2006.01); A61K 47/42 (2017.01); A61K 39/012 (2006.01); A61K 39/108 (2006.01); A61K 39/112 (2006.01); A61K 39/04 (2006.01); A61K 39/05 (2006.01); A61K 39/08 (2006.01); A61K 39/085 (2006.01); A61K 39/09 (2006.01); A61K 39/102 (2006.01); A61K 39/15 (2006.01); A61K 39/155 (2006.01); A61K 39/17 (2006.01); A61K 39/215 (2006.01); A61K 39/255 (2006.01); A61K 39/265 (2006.01);
U.S. Cl.
CPC ...
A61K 39/39 (2013.01); A61K 9/0019 (2013.01); A61K 9/06 (2013.01); A61K 39/00 (2013.01); A61K 39/0003 (2013.01); A61K 39/012 (2013.01); A61K 39/0208 (2013.01); A61K 39/0258 (2013.01); A61K 39/0275 (2013.01); A61K 39/04 (2013.01); A61K 39/05 (2013.01); A61K 39/08 (2013.01); A61K 39/085 (2013.01); A61K 39/092 (2013.01); A61K 39/099 (2013.01); A61K 39/102 (2013.01); A61K 39/104 (2013.01); A61K 39/1045 (2013.01); A61K 39/12 (2013.01); A61K 39/145 (2013.01); A61K 39/15 (2013.01); A61K 39/155 (2013.01); A61K 39/17 (2013.01); A61K 39/215 (2013.01); A61K 39/255 (2013.01); A61K 39/265 (2013.01); A61K 39/29 (2013.01); A61K 39/292 (2013.01); A61K 47/42 (2013.01); A61K 2039/5252 (2013.01); A61K 2039/53 (2013.01); A61K 2039/54 (2013.01); A61K 2039/545 (2013.01); A61K 2039/552 (2013.01); A61K 2039/55505 (2013.01); A61K 2039/55516 (2013.01); A61K 2039/55555 (2013.01); A61K 2039/55561 (2013.01); A61K 2039/55566 (2013.01); A61K 2039/575 (2013.01); C12N 2710/16334 (2013.01); C12N 2710/16734 (2013.01); C12N 2710/24034 (2013.01); C12N 2720/10034 (2013.01); C12N 2720/12334 (2013.01); C12N 2730/10134 (2013.01); C12N 2750/10034 (2013.01); C12N 2750/14334 (2013.01); C12N 2760/16134 (2013.01); C12N 2760/16171 (2013.01); C12N 2760/18034 (2013.01); C12N 2760/18134 (2013.01); C12N 2770/10034 (2013.01); C12N 2770/20034 (2013.01); C12N 2770/24334 (2013.01); C12N 2770/32334 (2013.01); Y02A 50/30 (2018.01);
Abstract
A vaccine delivery method is presented that includes a composition including as one component a slurry matrix that is a liquid at room temperature and a gel at physiological pH, physiological salt concentrations and/or physiological temperatures and as a second component one or more antigens. Also included are methods of inducing an immune response in a subject and vaccinating a subject by administering such compositions.